Front-Line Dexamethasone vs Prednisone for Patient Outcomes in Acute Immune Thrombocytopenia
Investigators compared first-line dexamethasone with prednisone on admission and readmission rates among patients with acute immune thrombocytopenia.
Investigators compared first-line dexamethasone with prednisone on admission and readmission rates among patients with acute immune thrombocytopenia.
A single-center study in Canada found a point prevalence of Gaucher disease of 0.5% among Canadian patients referred to a hematologist for thrombocytopenia.
There might be notable variations among hematology, oncology, and bone marrow transplant practitioners when treating thrombotic events in children with leukemia.
A team of researchers evaluated the current health system-wide practices and protocols associated with the administration of DOACs in anticoagulation clinics.
A team of investigators provided a real-world understanding of apixaban or rivaroxaban-linked acute bleeding events in patients receiving aPCC.
A DOAC population-based management tool may help determine and address potential interactions between DOACs and NSAIDs in patients receiving both treatments.
Epidural analgesia in pregnant women with VWD type 1 appears to be safe with VWF and factor VIII levels of 80% or more in the third trimester.
For patients with severe hemophilia A, N8-GP was safe and efficacious according to the results of the pathfinder clinical programs.
Patients with sickle cell disease may have an increased risk for venous thromboembolic events, especially pulmonary embolism, following surgical splenectomy.
A novel optical sensor accurately measures anticoagulation and global hemostasis in patients during cardiac surgery with cardiopulmonary bypass.